1 – 10 of 31
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Twenty years on from the introduction of the high risk strategy for stroke and cardiovascular disease prevention : a systematic scoping review
(
- Contribution to journal › Scientific review
-
Mark
Usability and feasibility of PreventS-MD web app for stroke prevention
(
- Contribution to journal › Article
- 2023
-
Mark
Factors Associated With Circulating Sex Hormones in Men
(
- Contribution to journal › Scientific review
- 2022
-
Mark
Time to revise primary prevention guidelines for stroke and cardiovascular disease
(
- Contribution to journal › Letter
-
Mark
Atrial Fibrillation and Dementia : A Report From the AF-SCREEN International Collaboration
(
- Contribution to journal › Scientific review
- 2021
-
Mark
Effects of Fluoxetine on Outcomes at 12 Months after Acute Stroke : Results from EFFECTS, a Randomized Controlled Trial
(
- Contribution to journal › Article
- 2020
-
Mark
The World Stroke Organization's Declaration for worldwide primary stroke and dementia prevention
(
- Contribution to journal › Article
-
Mark
Update on the EFFECTS study of fluoxetine for stroke recovery : A randomised controlled trial in Sweden
(
- Contribution to journal › Scientific review
-
Mark
What Is the Best Mix of Population-Wide and High-Risk Targeted Strategies of Primary Stroke and Cardiovascular Disease Prevention?
(
- Contribution to journal › Scientific review
-
Mark
Characteristics of Recurrent Ischemic Stroke after Embolic Stroke of Undetermined Source : Secondary Analysis of a Randomized Clinical Trial
(
- Contribution to journal › Article